Want to join the conversation?
$AMGN, the world's largest biotech company, raised its FY15 outlook. For FY15, revenue is expected to be $21.4-21.6Bil and adjusted EPS is anticipated to be $9.95-10.10 compared to $AMGN's previous estimate of $21.1-21.4Bil and $9.55-9.80, respectively. For FY16, $AMGN expects revenue to be $21.7-22.3Bil and adjusted EPS to be $10.35-10.75.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?